- Home
- MBWM vs RCKT Comparison
MBWM vs RCKT Comparison
Compare MBWM & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBWM
- RCKT
- Stock Information
- Founded
- MBWM 1997
- RCKT 1999
- Country
- MBWM United States
- RCKT United States
- Employees
- MBWM N/A
- RCKT N/A
- Industry
- MBWM Major Banks
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- MBWM Finance
- RCKT Health Care
- Exchange
- MBWM Nasdaq
- RCKT Nasdaq
- Market Cap
- MBWM 712.7M
- RCKT 764.5M
- IPO Year
- MBWM 1997
- RCKT N/A
- Fundamental
- Price
- MBWM $44.16
- RCKT $2.49
- Analyst Decision
- MBWM Buy
- RCKT Buy
- Analyst Count
- MBWM 2
- RCKT 11
- Target Price
- MBWM $52.25
- RCKT $21.77
- AVG Volume (30 Days)
- MBWM 44.8K
- RCKT 7.1M
- Earning Date
- MBWM 07-15-2025
- RCKT 05-08-2025
- Dividend Yield
- MBWM 3.35%
- RCKT N/A
- EPS Growth
- MBWM N/A
- RCKT N/A
- EPS
- MBWM 4.80
- RCKT N/A
- Revenue
- MBWM $222,296,000.00
- RCKT N/A
- Revenue This Year
- MBWM $8.87
- RCKT N/A
- Revenue Next Year
- MBWM $3.71
- RCKT N/A
- P/E Ratio
- MBWM $9.20
- RCKT N/A
- Revenue Growth
- MBWM 0.96
- RCKT N/A
- 52 Week Low
- MBWM $35.61
- RCKT $2.19
- 52 Week High
- MBWM $52.98
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- MBWM 50.31
- RCKT 24.93
- Support Level
- MBWM $43.38
- RCKT $2.19
- Resistance Level
- MBWM $45.08
- RCKT $2.67
- Average True Range (ATR)
- MBWM 1.22
- RCKT 0.54
- MACD
- MBWM -0.16
- RCKT -0.49
- Stochastic Oscillator
- MBWM 36.43
- RCKT 5.75
About MBWM Mercantile Bank Corporation
Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.